Bar Lab

The Bar Lab studies novel approaches to HIV prevention and cure.

Characterizing the viral dynamics and host immune responses during virus suppression and treatment interruption.

Scanning electron micrograph of HIV-1 virions (green) budding from a cultured lymphocyte. Multiple round bumps on the cell surface represent sites of virion assembly and budding. (Ref)

Developing Non-Human Primate (NHP) models that faithfully recapitulate HIV-1 latency and rebound.

Rhesus macaque (Macaca mulatta mulatta), male, Gokarna Forest, Near Kathmandu, Nepal (Ref)

Developing antibody-based interventions

A three-dimensional X-ray crystallographic image showing a broadly neutralizing antibody (green) bound to a vaccine target (yellow) on an HIV-1 gp120 molecule (red). Ref

Globally, 37.7 million people were living with HIV at the end of 2020. An estimated 0.7% of adults aged 15–49 years worldwide are living with HIV, although the burden of the epidemic continues to vary considerably between countries and regions.

Photo Credit: Ian Cuming/Getty

The Bar Lab studies novel approaches to HIV prevention and cure.

Characterizing the viral dynamics and host immune responses during virus suppression and treatment interruption.

Developing Non-Human Primate (NHP) models that faithfully recapitulate HIV-1 latency and rebound.

Developing antibody-based interventions

Globally, 37.7 million people were living with HIV at the end of 2020. An estimated 0.7% of adults aged 15–49 years worldwide are living with HIV, although the burden of the epidemic continues to vary considerably between countries and regions.